RHYTHM PHARMACEUTICALS INC's ticker is RYTM and the CUSIP is 76243J105. A total of 92 filers reported holding RHYTHM PHARMACEUTICALS INC in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $189,530,626 | +38.5% | 8,267,421 | -0.4% | 0.16% | +40.4% |
Q2 2023 | $136,855,737 | +0.8% | 8,299,317 | +9.1% | 0.11% | -3.4% |
Q1 2023 | $135,714,428 | -32.6% | 7,607,311 | +10.1% | 0.12% | -35.9% |
Q4 2022 | $201,252,455 | +16.9% | 6,911,142 | -1.6% | 0.18% | +10.2% |
Q3 2022 | $172,159,000 | +551.8% | 7,026,892 | +10.4% | 0.17% | +595.8% |
Q2 2022 | $26,411,000 | -63.6% | 6,364,094 | +1.1% | 0.02% | -56.4% |
Q1 2022 | $72,484,000 | +16.1% | 6,291,991 | +0.6% | 0.06% | +27.9% |
Q4 2021 | $62,445,000 | -22.6% | 6,256,991 | +1.2% | 0.04% | -24.6% |
Q3 2021 | $80,725,000 | -33.0% | 6,181,091 | +0.4% | 0.06% | -29.6% |
Q2 2021 | $120,489,000 | -5.7% | 6,153,691 | +2.5% | 0.08% | -9.0% |
Q1 2021 | $127,739,000 | -1.1% | 6,005,593 | +38.3% | 0.09% | -7.3% |
Q4 2020 | $129,102,000 | +66.7% | 4,342,491 | +21.5% | 0.10% | +50.0% |
Q3 2020 | $77,464,000 | -2.0% | 3,574,691 | +0.8% | 0.06% | -5.9% |
Q2 2020 | $79,049,000 | +46.6% | 3,544,791 | +0.1% | 0.07% | +28.3% |
Q1 2020 | $53,918,000 | +12.2% | 3,542,591 | +69.2% | 0.05% | +51.4% |
Q4 2019 | $48,071,000 | +801.6% | 2,093,691 | +747.7% | 0.04% | +775.0% |
Q3 2019 | $5,332,000 | – | 246,977 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
MPM ASSET MANAGEMENT LLC | 909,258 | $10,475,000 | 3.58% |
NEA Management Company, LLC | 4,912,306 | $56,590,000 | 1.64% |
RA Capital Management | 4,871,067 | $56,115,000 | 1.22% |
Pinz Capital Management, LP | 148,475 | $1,710,000 | 1.07% |
Samsara BioCapital, LLC | 345,293 | $3,978,000 | 1.00% |
Bell & Brown Wealth Advisors, LLC | 117,400 | $1,352,000 | 0.61% |
Rock Springs Capital Management LP | 1,237,026 | $14,251,000 | 0.36% |
ACT CAPITAL MANAGEMENT, LLC | 27,500 | $317,000 | 0.34% |
Endurant Capital Management LP | 105,792 | $1,219,000 | 0.32% |
Baker Brothers Advisors | 4,125,062 | $47,521,000 | 0.27% |